Name:
Burkholderia dolosa Vermis et al. 2004
DSM No.:
16088, Type strain dsm-16088 dsm16088 dsm 16088 Burkholderia dolosa
Strain designation:
AU0645, R-5670
Other collection no.
or WDCM no.:
LMG 18943,CCUG 47727
Isolated from:
sputum of cystic fibrosis patient
Country:
United States of America
Date of sampling:
before 08.12.2003
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- LMG <- T. Coenye, Univ. Ghent, Belgium; R-5670 <- J. J. LiPuma, Philadelphia USA; AU0645
Summary and
additional information:
<- LMG <- T. Coenye, Univ. Ghent, Belgium; R-5670 <- J. J. LiPuma, Philadelphia USA; AU0645. Sputum of cystic fibrosis patient; USA. Type strain. Taxonomy/description (9145, 9146). Phylogeny (8169). (Medium 220, 28°C)
Risk group:
2 (classification according to German
TRBA)
Restrictions:
Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz),
Category A1
Supplied as:
| Delivery form | | Prices |
|
| Freeze Dried | | 100,- € |
| Active culture on request | | 240,- € |
| DNA | | 150,- € | |
| Price Category for this culture: 1 |
Freight and handling charges will be added.
See price list.Note: Freight charges for Risk Group 2 microorganisms will apply.
